Clinical Trial

Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals

Recruiting
View on ClinicalTrials.gov →
Summary
The investigators recently demonstrated a increase in liver fat in early middle-aged LBW compared to normal birth weight (NBW) men, and 20% of the LBW - but none of the normal birth weight (NBW) - men had previously unknown non-alcoholic fatty liver disease (NAFLD). Here the investigators will further examine the Increased risk of non-alcoholic fatty liver disease in low birth weight individuals by performing a validation study.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-05-26; most recent amendment 2026-06-09.
Status change: Not Yet Recruiting → Recruiting 2024-04-18
Trial Details
NCT Number NCT05890365
Lead Sponsor Steno Diabetes Center Copenhagen
Collaborators: Aarhus University Hospital, Lund University
Conditions Non-Alcoholic Fatty Liver Disease, Low Birth Weight
Enrollment 300 participants
Start Date 2023-12-14
Primary Completion 2026-06 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-11